臨床整形外科51巻4号

2016年04月発行

誌上シンポジウム THA後感染の予防・診断・治療の最前線

感染人工股関節に対する治療法の選択

著者： 䯨賢一¹ 飯田寛和¹

所属機関： ¹関西医科大学整形外科学教室

ページ範囲：P.327 - P.335

　人工関節周囲感染の治療は，洗浄・デブリドマン，一期的再置換術，二期的再置換術などの選択肢がある．術後早期の場合，洗浄・デブリドマンも可能だが，感染の本質はバイオフィルムであることからインプラント抜去を要することが多く，条件を満たせば一期的再置換術も可能である．人工関節周囲感染は悩ましい合併症の1つだが，正しく治療すれば寛解率は90％以上である．

参考文献

1）Dale H, Fenstad AM, Hallan G, et al. Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop 2012;83:449-58.

2）Gundtoft PH, Overgaard S, Schønheyder HC, et al. The “true” incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties. Acta Orthop 2015;86:326-34.

3）䯨　賢一，和田孝彦，飯田寛和．感染人工股関節に対する人工股関節の治療成績．整・災外2009；52：75-81.

4）䯨　賢一，和田孝彦，飯田寛和．感染人工股関節に対する治療戦略：一期的・二期的再置換術．整・災外2010；53：555-62.

5）Oe K, Iida H, Ueda N, et al. Pre-operative scoring system to determine the surgical strategy for periprosthetic hip infection. Int Orthop 2015;39:19-25.

6）䯨　賢一，飯田寛和．PJI治療(一期的または二期的再置換術)②THA．関節外科2015；34：885-92.

7）Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996;78:512-23.

8）Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms:a common cause of persistent infections. Science 1999;21:1318-22.

9）Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection:clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013;56:e1-e25.

10）Parvizi J, Zmistowski B, Berbari EF, et al. New definition for periprosthetic joint infection:from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 2011;469:2992-4.

11）Parvizi J, Gehrke T. Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection. J Orthop Res 2014;32:S1-172.

12）Choi HR, Kwon YM, Freiberg AA, et al. Periprosthetic joint infection with negative culture results:clinical characteristics and treatment outcome. J Arthroplasty 2013;28:899-903.

13）植田成実，䯨　賢一，中村知寿・他．超音波処理によるインプラント周囲感染診断．整・災外2015；58：91-7.

14）Byren I, Bejon P, Atkins BL, et al. One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention):antibiotic duration and outcome. J Antimicrob Chemother 2009;63:1264-71.

15）Waagsbø B, Sundøy A, Martinsen TM, et al. Treatment results with debridement and retention of infected hip prostheses. Scand J Infect Dis 2009;41:563-8.

16）Choi HR, von Knoch F, Kandil AO, et al. Retention treatment after periprosthetic total hip arthroplasty infection. Int Orthop 2012;36:723-29.

17）Fehring TK, Odum SM, Berend KR, et al. Failure of irrigation and débridement for early postoperative periprosthetic infection. Clin Orthop Relat Res 2013;471:250-7.

18）Triantafyllopoulos GK, Poultsides LA, Sakellariou VI, et al. Irrigation and debridement for periprosthetic infections of the hip and factors determining outcome. Int Orthop 2015;39:1203-09.

19）Jiranek WA, Waligora AC, Hess SR, et al. Surgical treatment of prosthetic joint infections of the hip and knee:Changing paradigms? J Arthroplasty 2015;30:912-8.

20）Carlsson AS, Josefsson G, Lindberg L. Revision with gentamicin-impregnated cement for deep infections in total hip arthroplasties. J Bone Joint Surg Am 1978;60:1059-64.

21）Buchholz HW, Engelbrecht H. Uber die Depotwirkung einiger Antibiotica bei Vermischung mit dem Kunstharz Palacos. Chirurg 1970;41:511-5.

22）日本整形外科学会診療ガイドライン委員会．骨・関節術後感染予防ガイドライン：2006．南江堂：p.21-2.

23）Berend KR, Lombardi AV Jr, Morris MJ, et al. Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res 2013;471:510-18.

24）Garvin KL, Hanssen AD. Infection after total hip arthroplasty. Past, present, and future.J Bone Joint Surg Am 1995;77:1576-88.

25）Masri BA. Sepsis;two-stage exchange. Callaghan RR. The Adult Hip. 1st ed. Philadelphia:Lippincott Williams ＆ Wilkins:1998, p.1317-30.

26）Jackson WO, Schmalzried TP. Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res 2000;381:101-5.

27）Langlais F. Can we improve the results of revision arthroplasty for infected total hip replacement? J Bone Joint Surg Br 2003;85:637-40.

28）Beswick AD, Elvers KT, Smith AJ, et al. What is the evidence base to guide surgical treatment of infected hip prostheses? systematic review of longitudinal studies in unselected patients. BMC Med 2012;10:18.

29）Lange J, Troelsen A, Thomsen RW, et al. Chronic infections in hip arthroplasties:comparing risk of reinfection following one-stage and two-stage revision:a systematic review and meta-analysis. Clin Epidemiol 2012;4:57-73.

30）Leonard HA, Liddle AD, Burke O, et al. Single- or two-stage revision for infected total hip arthroplasty? A systematic review of the literature. Clin Orthop Relat Res 2014;472:1036-42.

31）Buchholz HW, Elson RA, Engelbrecht E, et al. Management of deep infection of total hip replacement. J Bone Joint Surg Br 1981;63:342-53.

32）Gehrke T, Zahar A, Kendoff D. One-stage exchange:it all began here. Bone Joint J 2013;95:77-83.

33）Morley JR, Blake SM, Hubble MJ, et al. Preservation of the original femoral cement mantle during the management of infected cemented total hip replacement by two-stage revision. J Bone Joint Surg Br 2012;94:322-7.

34）Vielgut I, Sadoghi P, Wolf M, et al. Two-stage revision of prosthetic hip joint infections using antibiotic-loaded cement spacers:When is the best time to perform the second stage? Int Orthop 2015;39:1731-6.

35）Stevens CM, Tetsworth KD, Calhoun JH, et al. An articulated antibiotic spacer used for infected total knee arthroplasty:a comparative in vitro elution study of Simplex and Palacos bone cements. J Orthop Res 2005;23:27-33.

36）Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am 2006;88:2487-500.

37）Moojen DJ, Hentenaar B, Charles Vogely H, et al. In vitro release of antibiotics from commercial PMMA beads and articulating hip spacers. J Arthroplasty 2008;23:1152-6.

38）Anagnostakos K, Wilmes P, Schmitt E, et al. Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta Orthop 2009;80:193-7.

39）Hansen EN, Adeli B, Kenyon R, et al. Routine use of antibiotic laden bone cement for primary total knee arthroplasty:impact on infecting microbial patterns and resistance profiles. J Arthroplasty 2014;29:1123-27.

40）Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004;351:1645-54.

41）Brandt CM, Duffy MC, Berbari EF, et al. Staphlococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin Proc 1999;74:553-8.

42）Stockley I, Mockford BJ, Hoad-Reddick A, et al. The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br 2008;90:145-8.

43）Miley GB, Scheller AD Jr, Turner RH. Medical and surgical treatment of the septic hip with one-stage revision arthroplasty. Clin Orthop Relat Res 1982;170:76-82.

44）Wroblewski BM. One-stage revision of infected cemented total hip arthroplasty. Clin Orthop Relat Res 1986;211:103-7.

45）Raut VV, Siney PD, Wroblewski BM. One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg Br 1994;76:721-4.

46）Ure KJ, Amstutz HC, Nasser S, et al. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am 1998;80:961-8.

47）Callaghan JJ, Katz RP, Johnston RC. One-stage revision surgery of the infected hip. A minimum 10-year followup study. Clin Orthop Relat Res 1999;369:139-43.

48）Rudelli S, Uip D, Honda E, et al. One-stage revision of infected total hip arthroplasty with bone graft. J Arthroplasty 2008;23:1165-77.

49）Jenny JY, Lengert R, Diesinger Y, et al. Routine one-stage exchange for chronic infection after total hip replacement. Int Orthop 2014;38:2477-81.

50）Zeller V, Lhotellier L, Marmor S, et al. One-stage exchange arthroplasty for chronic periprosthetic hip infection:results of a large prospective cohort study. J Bone Joint Surg Am 2014;96:e1(1)-(9).

51）Sanzén L, Carlsson AS, Josefsson G, et al. Revision operations on infected total hip arthroplasties. Two- to nine-year follow-up study. Clin Orthop Relat Res 1988;229:165-72.

52）Hope PG, Kristinsson KG, Norman P, et al. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br 1989;71:851-5.

53）Elson RA. Exchange arthroplasty for infection. Perspectives from the United Kingdom. Orthop Clin North Am 1993;24:761-7.

54）Garvin KL, Evans BG, Salvati EA, et al. Palacos gentamicin for the treatment of deep periprosthetic hip infections. Clin Orthop Relat Res 1994;298:97-105.

55）Giulieri SG, Graber P, Ochsner PE, et al. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 2004;32:222-8.

56）Oussedik SI, Dodd MB, Haddad FS. Outcomes of revision total hip replacement for infection after grading according to a standard protocol. J Bone Joint Surg Br 2010;92:1222-6.

57）Klouche S, Leonard P, Zeller V, et al. Infected total hip arthroplasty revision:one- or two-stage procedure? Orthop Traumatol Surg Res 2012;98:144-50.

58）Choi HR, Kwon YM, Freiberg AA, et al. Comparison of one-stage revision with antibiotic cement versus two-stage revision results for infected total hip arthroplasty. J Arthroplasty 2013;28:66-70.

59）Wolf M, Clar H, Friesenbichler J, et al. Prosthetic joint infection following total hip replacement:results of one-stage versus two-stage exchange. Int Orthop 2014;38:1363-8.